Profil electroneuromyographique des neuropathies dans une population de patients diabetiques admis dans un laboratoire de neurophysiologie

Les neuropathies périphériques constituent une complication fréquente du diabète. Plusieurs formes de neuropathies sont décrites dans cette population. L’objectif de ce travail était d’étudier la fréquence desdifférentes neuropathies dans une population de diabétiques.Nous avons réalisé une étude descriptive portant sur 110 patients diabétiques admis dans le laboratoire de Neurophysiologie du CHU de Limoges de janvier 2004 à juin 2006. Le diagnostic EMG des neuropathies démyélinisantes était basé sur les critères de l’EFNS/PNS. Il s’agit de 110 sujets dont 63 de sexe masculin, âgés de 18 à 81 ans avec un âge moyen de 57,2 ans. La durée moyenne de la maladie était de 15 ans avec un taux moyen de HbA1C de 7,9%.33 sujets (30,6%) avaient une neuropathie démyélinisante dont 20 classés défini, 8 probable et 5 possible. 25,2% avaient une neuropathie axonale, 22,7% un syndrome du canal carpien et 14 sujets avaient un EMG normal. Ces résultats comparables à certains de la littérature suggèrent une fréquence assez élevée des neuropathies démyélinisantes chez les diabétiques et imposent d’en étudier les déterminants

Evolution de la diversité des cultivars de fonio pratiqués dans la commune de Boukoumbé au Nord-Ouest du Bénin

Afin de comparer la diversité actuelle des écotypes de fonio à celle cultivée dix (10) ans plus tôt au Bénin, une enquête a été menée en 2013 dans la commune de Boukoumbé. Dans chacun des vingt (20) villages prospectés, un focus groupe d’une douzaine de producteurs a été à chaque fois enquêté. Cinq (5) à dix (10) producteurs sont ensuite entretenus individuellement à l’aide d’un questionnaire semi-structuré pour recueillir des informations sur les cultivars, leurs noms locaux, leurs principales caractéristiques, et la gestion des semences. Les résultats ont confirmé la diversité des appellations et ont permis de recenser cinq (5) cultivars différenciés par la précocité, la couleur des racèmes, les tailles de graines et de plantes. Les semences, transmises surtout de génération en génération, sont prélevées à 99% sur les récoltes précédentes. Près de 95% des enquêtés cultivent une seule variété à la fois. La plus forte diversité a été rencontrée chez les "Ditamaris" des villages de Boukoumbé-centre et Natta. "Iporapia" et "Takotapuaka" sont cultivés par toutes les ethnies. La diversité décrite dix (10) ans plus tôt dans la zone a été maintenue. Toutefois, les variétés de précocités extrêmes sont de moins en moins cultivées, et donc menacées de disparition.© 2015 International Formulae Group. All rights reserved.Mots clés: Espèce négligée, accession de fonio, Digitalia spp., conservation in situ, amélioration variétale, BéninEnglish Title: Evolution of the diversity of fonio cultivars practiced in the commune of Boukoumbe in North-West of BeninEnglish AbstractTo compare the current diversity of landraces of millet fonio to that cultivated ten (10) years ago in Benin, a survey was conducted in 2013 in the district of Boukoumbé. In each of the twenty (20) villages surveyed a focus group of a dozen producers was investigated every time. Then, five (5) to ten (10) producers are individually interviewed using a semi-structured questionnaire to collect information on cultivars, their local names, their main characteristics and seed management. The results confirmed the diversity of names and allowed to identify five cultivars differentiated by the earliness, color of racemes, sizes of seeds and plant height. Seeds, especially transmitted from generation to generation, are taken at 99% on the previous harvest. Nearly 95% of respondents grow only one variety at a time. The greatest diversity was encountered among the "Ditamaris" of villages in Boukoumbé center and Natta. "Iporapia" and "Takotapuaka" are cultivated by all ethnic groups. The diversity described ten (10) years earlier in the area has been maintained. However, the extreme precocity varieties are lesser and lesser grown, and therefore at risk of extinction.© 2015 International Formulae Group. All rights reserved.Keywords: Neglected species, accession of fonio, Digitaria spp, in situ conservation, plant breeding, Beni

Usages Et Vulnerabilite De Pterocarpus Santalinoides L'her. Ex De (Papillionoidae), Une Plante Utilisee Dans Le Traitement Des Gastro-Enterites Dans Le Sud Du Benin

In West Africa, rural populations depend heavily on woody plant resources to satisfy particular nutritional and therapeutic needs. This study was conducted in South of Benin to identify local knowledge about Pterocarpus santalinoides, and its vulnerability level. Investigations were made using an interview guide followed by observations. 180 professionals were interviewed. It appears from the study that the "African teak" is known as 10 local designations. The species is sought in many areas of use (African medicine, food medicine, carpentry, art, energy and well-being). On medicinal plan, leaves, bark of the trunk and roots are solicited alone or in association with others to treat especially the symptoms related to gastroenteric (diarrhoea, dysentery, vomiting and abdominal cramps). Decoct is the main galenic form adopted for the treatment of these conditions. Considering all the sectors, all its vegetative organs are used. Degree of uses of various organs of this plant is the main causes of its vulnerability. Vulnerability index (Iv) is equal to 2.4. The species is thus identified as vulnerable. It is urgent for its users to adopt a sustainable management approach, in order to preserve African teak

Caracterisation Des Systemes De Production A Base D’anacardier Dans Les Principales Zones De Culture Au Benin

Les données relatives aux caractéristiques socio-économiques des producteurs d’anacarde, aux pratiques de gestion des plantations, aux intrants et aux revenus de la production ont été collectées à l’aide d’unquestionnaire administré à 349 planteurs issus des principales zones de production du Bénin. Le modèle de la rentabilité économique de COBB-DOUGLAS a été utilisé pour évaluer les déterminants du revenuannuel obtenu de la vente des noix d’anacarde. La majorité des planteurs d’anacardier sont des autochtones (93,1 %), dont 89,7 % hommes parmi lesquels 87,4 % sont des héritiers de plantation. L’anacardier génèredes revenus pour 97,42 % des personnes enquêtées. L’association culturale avec l’anacardier est pratiquée lorsque l’arbre est au stade juvénile (moins de 10 ans). Le manque d’entretien des plantations et la non utilisation d’intrants ne permettent pas une augmentation substantielle des rendements en pomme et en noix au niveau des différentes zones de production. Le revenu annuel obtenu de la vente des noix d’anacarde est significativement influencé par la superficie emblavée (P < 0,05 à P < 0,001), le coût total de la main-d’oeuvre, le rendement des noix, le prix de vente du kilogramme de noix, la situation matrimoniale du producteur et l’accès aux crédits.Mots clés : Systèmes de culture, anacardier, gestion des plantations, rentabilité économique, Bénin. Data such as farmers’ socio-economic characteristics, management of cashew trees, inputs and outputs related to the production systems have been collected from 349 farmers. The economic profitability model of COBB-DOUGLAS was used to assess the determinants of the annual income generated by cashew nut. The majority of farmers are natives (93.1 %), men (89.7 %) and heirs of the plantation (87.4 %). Cashew generates income for 97.42 % of the respondents. The annual crops are intercropped with cashew when the tree is young. Lack of field keeping and non use of inputs especially fertilizer affect substantially the increase of nuts and apple yields in the study area. The annual income obtained from the marketing of cashew nut is significantly influenced (P < 0.05 à P < 0.001) by the area of cashew plantation, the cost of labor, the nut yield, the price of the nut, the marital situation of farmer and the access to credit.Key words: cropping systems, cashew tree, plantations management, economic profitability, Benin. Article in French

ANTIMICROBIAL, ANTIOXIDANT, CYTOTOXIC ACTIVITIES AND PHYTOCHEMICAL ASSESSMENT OF COLA ACUMINATA USED IN BENIN

Objective: The aim of this study was to make a phytochemical screening and measure some biological activities of Cola acuminata's seeds and leaves extracts.Methods: The secondary metabolite was detected by the method based on coloring and precipitation differential reactions. The antibacterial and antifungal activities were assessed in vitro by the macrodillution and solid medium agar diffusion method. 2,2-diphényl-1-picrylhydrazyl (DPPH) and 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) methods were used to evaluate the antioxidant activity of the tested extracts of which larval cytotoxicity was studied.Results: Our data revealed that the seeds contain more polyphenols than the leaves. The seeds extracts displayed a good antibacterial activity against both reference strains and food Staphylococcus strains. The inhibition diameters varied from 7±2.82 to 21.5±4.94 mm. The smallest Minimum Inhibitory Concentrations (MIC) on the food strains (0.08 mg/ml) is twice less than the reference strains one (0.15 mg/ml), this observation is contrary to the Minimum Bactericidal concentrations (MBC). Susceptibility of fungal strains varies according to the extracts (p = 0.0016). The seeds ethyl acetate extracts had the best antioxidant activity with DPPH and ABTS methods. The Lethal Doses (LD50) showed that no extract was toxic.Conclusion: Cola acuminata seeds are richer than the leaves in compounds with biological activities. These two organs have interesting antimicrobial, antifungal and antioxidant activity variables depending to the extracts. The seeds have better biological activity than the leaves.Â

Stroke in Africa: Profile, progress, prospects and priorities

Funding text 1 R.O.A. is supported by the UK Royal Society/African Academy of Sciences FLAIR Grants FLR/R1/191813 and FCG/R1/ 201034, and a GCRF Networking Grant from the UK Academy of Medical Sciences. R.O.A., M.O.O., B.O. and F.S.S. are also supported by grants U54HG007479 and U01HG010273 from the US National Institutes of Health (NIH) as part of the H3Africa Consortium. M.O.O., B.O., R.O.A. and F.S.S. are further supported by NIH grant R01NS107900. R.N.K.’s research on elderly survivors of stroke has been supported by the Medical Research Council, RCUK Newcastle Centre for Brain Ageing and Vitality (MRC G0500247), Alzheimer’s Research UK, the Dunhill Medical Trust, UK, and the Newcastle National Institute for Health Research Biomedical Research Centre in Ageing and Age-Related Diseases, Newcastle upon Tyne Hospitals National Health Service Foundation Trust. Funding text 2 funds provided by the Wellcome Trust and the NIH. The NIH-funded SIREN study is exploring the genetic architecture of stroke among Indigenous Africans. More than 4,000 case–control pairs have already been recruited to the study and several publications on stroke phenom-ics and preliminary candidate gene analyses have been generated. The SIREN study has also undertaken the first-ever GWAS to unravel the genetic architecture of stroke in Indigenous Africans and the results are eagerly awaited. Stroke neurobanking resources consisting of blood fractions, extracted DNA, neuroimages and databases of clinical information are also being built in Africa and could facilitate data science-driven trans-omics research (including epigenomics, tran-scriptomics, proteomics and metabolomics) as well as the development of precision medicine products such as Afrocentric risk calculators, polygenic risk scores, biomarkers and drug targets23–25,227,307,308. The SIREN neurobiobank comprises a group of constantly monitored ultra-low-temperature (–86 °C) freezers located in Ibadan, Nigeria, constantly powered –20 °C chest freezers located in Ibadan and other recruitment sites, barcode scanners and printers, a laboratory information management system, a secure multi-terabyte server,Stroke is a leading cause of disability, dementia, and death worldwide. Approximately 70% of deaths from stroke and 87% of stroke-related disabilities occur in low-income and middle-income countries. At the turn of the century, the most common diseases in Africa were communicable diseases, whereas non-communicable diseases, including stroke, were considered rare, particularly in sub-Saharan Africa. However, evidence indicates that today, Africa could have up to 2–3-fold greater rates of stroke incidence and higher stroke prevalence than western Europe and the USA. In Africa, data published within the past decade show that stroke has an annual incidence rate of up to 316 per 100,000, a prevalence of up to 1,460 per 100,000, and a 3-year fatality rate greater than 80%. Moreover, many Africans have a stroke within the fourth to sixth decades of life, with serious implications for the individual, their family, and society. This age profile is particularly important as strokes in younger people tend to result in a greater loss of self-worth and socioeconomic productivity than in older individuals. Emerging insights from research into stroke epidemiology, genetics, prevention, care, and outcomes offer great prospects for tackling the growing burden of stroke on the continent. In this article, we review the unique profile of stroke in Africa and summarize current knowledge on stroke epidemiology, genetics, prevention, acute care, rehabilitation, outcomes, cost of care, and awareness. We also discuss knowledge gaps, emerging priorities, and future directions of stroke medicine for the more than 1 billion people who live in Africa. © 2021, Springer Nature Limited.Newcastle National Institute for Health Research Biomedical Research Centre in Ageing and Age-Related Diseases Newcastle upon Tyne Hospitals National Health Service Foundation Trust RCUK Newcastle Centre for Brain Ageing and Vitality Royal Society/African Academy of Sciences: FCG/R1/ 201034,FLR/R1/191813 National Institutes of Health (NIH): R01NS107900 Wellcome Trust (WT) Medical Research Council (MRC): G0500247 Dunhill Medical Trust (DMT) Academy of Medical Sciences: U01HG010273,U54HG007479 Alzheimer’s Research UK (ARUK

Primary stroke prevention worldwide : translating evidence into action

Funding Information: The stroke services survey reported in this publication was partly supported by World Stroke Organization and Auckland University of Technology. VLF was partly supported by the grants received from the Health Research Council of New Zealand. MOO was supported by the US National Institutes of Health (SIREN U54 HG007479) under the H3Africa initiative and SIBS Genomics (R01NS107900, R01NS107900-02S1, R01NS115944-01, 3U24HG009780-03S5, and 1R01NS114045-01), Sub-Saharan Africa Conference on Stroke Conference (1R13NS115395-01A1), and Training Africans to Lead and Execute Neurological Trials & Studies (D43TW012030). AGT was supported by the Australian National Health and Medical Research Council. SLG was supported by a National Heart Foundation of Australia Future Leader Fellowship and an Australian National Health and Medical Research Council synergy grant. We thank Anita Arsovska (University Clinic of Neurology, Skopje, North Macedonia), Manoj Bohara (HAMS Hospital, Kathmandu, Nepal), Denis ?erimagi? (Poliklinika Glavi?, Dubrovnik, Croatia), Manuel Correia (Hospital de Santo Ant?nio, Porto, Portugal), Daissy Liliana Mora Cuervo (Hospital Moinhos de Vento, Porto Alegre, Brazil), Anna Cz?onkowska (Institute of Psychiatry and Neurology, Warsaw, Poland), Gloria Ekeng (Stroke Care International, Dartford, UK), Jo?o Sargento-Freitas (Centro Hospitalar e Universit?rio de Coimbra, Coimbra, Portugal), Yuriy Flomin (MC Universal Clinic Oberig, Kyiv, Ukraine), Mehari Gebreyohanns (UT Southwestern Medical Centre, Dallas, TX, USA), Ivete Pillo Gon?alves (Hospital S?o Jos? do Avai, Itaperuna, Brazil), Claiborne Johnston (Dell Medical School, University of Texas, Austin, TX, USA), Kristaps Jurj?ns (P Stradins Clinical University Hospital, Riga, Latvia), Rizwan Kalani (University of Washington, Seattle, WA, USA), Grzegorz Kozera (Medical University of Gda?sk, Gda?sk, Poland), Kursad Kutluk (Dokuz Eylul University, ?zmir, Turkey), Branko Malojcic (University Hospital Centre Zagreb, Zagreb, Croatia), Micha? Maluchnik (Ministry of Health, Warsaw, Poland), Evija Migl?ne (P Stradins Clinical University Hospital, Riga, Latvia), Cassandra Ocampo (University of Botswana, Princess Marina Hospital, Botswana), Louise Shaw (Royal United Hospitals Bath NHS Foundation Trust, Bath, UK), Lekhjung Thapa (Upendra Devkota Memorial-National Institute of Neurological and Allied Sciences, Kathmandu, Nepal), Bogdan Wojtyniak (National Institute of Public Health, Warsaw, Poland), Jie Yang (First Affiliated Hospital of Chengdu Medical College, Chengdu, China), and Tomasz Zdrojewski (Medical University of Gda?sk, Gda?sk, Poland) for their comments on early draft of the manuscript. The views expressed in this article are solely the responsibility of the authors and they do not necessarily reflect the views, decisions, or policies of the institution with which they are affiliated. We thank WSO for funding. The funder had no role in the design, data collection, analysis and interpretation of the study results, writing of the report, or the decision to submit the study results for publication. Funding Information: The stroke services survey reported in this publication was partly supported by World Stroke Organization and Auckland University of Technology. VLF was partly supported by the grants received from the Health Research Council of New Zealand. MOO was supported by the US National Institutes of Health (SIREN U54 HG007479) under the H3Africa initiative and SIBS Genomics (R01NS107900, R01NS107900-02S1, R01NS115944-01, 3U24HG009780-03S5, and 1R01NS114045-01), Sub-Saharan Africa Conference on Stroke Conference (1R13NS115395-01A1), and Training Africans to Lead and Execute Neurological Trials & Studies (D43TW012030). AGT was supported by the Australian National Health and Medical Research Council. SLG was supported by a National Heart Foundation of Australia Future Leader Fellowship and an Australian National Health and Medical Research Council synergy grant. We thank Anita Arsovska (University Clinic of Neurology, Skopje, North Macedonia), Manoj Bohara (HAMS Hospital, Kathmandu, Nepal), Denis Čerimagić (Poliklinika Glavić, Dubrovnik, Croatia), Manuel Correia (Hospital de Santo António, Porto, Portugal), Daissy Liliana Mora Cuervo (Hospital Moinhos de Vento, Porto Alegre, Brazil), Anna Członkowska (Institute of Psychiatry and Neurology, Warsaw, Poland), Gloria Ekeng (Stroke Care International, Dartford, UK), João Sargento-Freitas (Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal), Yuriy Flomin (MC Universal Clinic Oberig, Kyiv, Ukraine), Mehari Gebreyohanns (UT Southwestern Medical Centre, Dallas, TX, USA), Ivete Pillo Gonçalves (Hospital São José do Avai, Itaperuna, Brazil), Claiborne Johnston (Dell Medical School, University of Texas, Austin, TX, USA), Kristaps Jurjāns (P Stradins Clinical University Hospital, Riga, Latvia), Rizwan Kalani (University of Washington, Seattle, WA, USA), Grzegorz Kozera (Medical University of Gdańsk, Gdańsk, Poland), Kursad Kutluk (Dokuz Eylul University, İzmir, Turkey), Branko Malojcic (University Hospital Centre Zagreb, Zagreb, Croatia), Michał Maluchnik (Ministry of Health, Warsaw, Poland), Evija Miglāne (P Stradins Clinical University Hospital, Riga, Latvia), Cassandra Ocampo (University of Botswana, Princess Marina Hospital, Botswana), Louise Shaw (Royal United Hospitals Bath NHS Foundation Trust, Bath, UK), Lekhjung Thapa (Upendra Devkota Memorial-National Institute of Neurological and Allied Sciences, Kathmandu, Nepal), Bogdan Wojtyniak (National Institute of Public Health, Warsaw, Poland), Jie Yang (First Affiliated Hospital of Chengdu Medical College, Chengdu, China), and Tomasz Zdrojewski (Medical University of Gdańsk, Gdańsk, Poland) for their comments on early draft of the manuscript. The views expressed in this article are solely the responsibility of the authors and they do not necessarily reflect the views, decisions, or policies of the institution with which they are affiliated. We thank WSO for funding. The funder had no role in the design, data collection, analysis and interpretation of the study results, writing of the report, or the decision to submit the study results for publication. Funding Information: VLF declares that the PreventS web app and Stroke Riskometer app are owned and copyrighted by Auckland University of Technology; has received grants from the Brain Research New Zealand Centre of Research Excellence (16/STH/36), Australian National Health and Medical Research Council (NHMRC; APP1182071), and World Stroke Organization (WSO); is an executive committee member of WSO, honorary medical director of Stroke Central New Zealand, and CEO of New Zealand Stroke Education charitable Trust. AGT declares funding from NHMRC (GNT1042600, GNT1122455, GNT1171966, GNT1143155, and GNT1182017), Stroke Foundation Australia (SG1807), and Heart Foundation Australia (VG102282); and board membership of the Stroke Foundation (Australia). SLG is funded by the National Health Foundation of Australia (Future Leader Fellowship 102061) and NHMRC (GNT1182071, GNT1143155, and GNT1128373). RM is supported by the Implementation Research Network in Stroke Care Quality of the European Cooperation in Science and Technology (project CA18118) and by the IRIS-TEPUS project from the inter-excellence inter-cost programme of the Ministry of Education, Youth and Sports of the Czech Republic (project LTC20051). BN declares receiving fees for data management committee work for SOCRATES and THALES trials for AstraZeneca and fees for data management committee work for NAVIGATE-ESUS trial from Bayer. All other authors declare no competing interests. Publisher Copyright: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licenseStroke is the second leading cause of death and the third leading cause of disability worldwide and its burden is increasing rapidly in low-income and middle-income countries, many of which are unable to face the challenges it imposes. In this Health Policy paper on primary stroke prevention, we provide an overview of the current situation regarding primary prevention services, estimate the cost of stroke and stroke prevention, and identify deficiencies in existing guidelines and gaps in primary prevention. We also offer a set of pragmatic solutions for implementation of primary stroke prevention, with an emphasis on the role of governments and population-wide strategies, including task-shifting and sharing and health system re-engineering. Implementation of primary stroke prevention involves patients, health professionals, funders, policy makers, implementation partners, and the entire population along the life course.publishersversionPeer reviewe

An Estimate of the Incidence and Prevalence of Stroke in Africa:A Systematic Review and Meta-Analysis

Background: Stroke is increasingly becoming a challenging public health issue in Africa, and the non-availability of data has limited research output and consequently the response to this burden. This study aimed to estimate the incidence and prevalence of stroke in Africa in 2009 towards improved policy response and management of the disease in the region. Methods: A systematic search of Medline, EMBASE and Global Health for original population-based or hospital-based studies on stroke was conducted. A random effect meta-analysis was conducted on crude stroke incidence and prevalence rates, and a meta-regression-like epidemiological model was applied on all data points. The fitted curve generated from the model was used to estimate incident cases of stroke and number of stroke survivors in Africa at midpoints of the United Nation population 5-year age groups for the year 2009. Results: The literature search yielded a total of 1227 studies. 19 studies from 10 African countries were selected. 483 thousand new stroke cases among people aged 15 years or more were estimated in Africa in 2009, equivalent to 81.2 (13.2– 94.9)/100,000 person years. A total of 1.89 million stroke survivors among people aged 15 years or more were estimated in Africa in 2009, with a prevalence of 317.3 (314.0–748.2)/100000 population. Comparable figures for the year 2013 based on the same rates would amount to 535 thousand (87.0–625.3) new stroke cases and 2.09 million (2.06–4.93) stroke survivors, suggesting an increase of 10.8% and 9.6% of incident stroke cases and stroke survivors respectively, attributable to population growth and ageing between 2009 and 2013. Conclusion: The findings of this review suggest the burden of stroke in Africa is high and still increasing. There is need for more research on stroke and other vascular risk factors towards instituting appropriate policy, and effective preventive and management measures

Prévalence de la migraine à Titirou en 2017.

International audienc

Communication de la session de Nutrition CHEMICAL COMPOSITION OF SOME RAW MATERIALS AVAILABLE FOR RABBIT FEEDING IN BENIN

Résumé français Composition chimique de quelques matières premières disponibles pour l'alimentation du lapin au Bénin Au cours des 10 dernières années différentes analyses ont été réalisées sur 25 matières premières utilisées au Bénin pour l'alimentation des lapins. L'objectif de la présente communication est de rendre cette information disponible pour tous. Les produits étudié ont été 9 fourrages séchés au soleil (( ABSTRACT During the past ten years various chemical analyses of 25 raw materials used in Benin for rabbit feeding were performed. The aim of the present paper is to make this information available for a maximum of potential users. The studied products were 9 sun dried forages (Albizia chevalierii foliage, Bidens pilosa whole plant, Cajanus cajan foliage, Desmodium scorpiurus vines, Leucaena leucocephala foliage, Manihot esculenta foliage, Puerearia phaseolides whole plant, Samanea saman foliage, Sida acuta foliage), 7 energy sources (cashew industry by-product, maize germ, maize grain (white), cassava peels, cassava root chips, wheat bran and maize bran), 3 industrial fiber sources (cassava distillery by-product, rice hulls and teak wood sawdust) and 6 protein sources (local fish meal, local toasted soybean seeds, local cottonseed meal, local palm kernel meal, imported soybean meal and local brewers grain). The nutrients analyzed were dry mater (DM), crude protein (CP), ash, crude fiber, ether extract, neutral detergent fiber (NDF), acid detergent fiber (ADF), lignin (ADL) and gross energy. In addition for 8 forages and 5 other raw materials mineral composition was determined for calcium, phosphorus, magnesium, sodium and potassium. All were expressed as percentage of DM. It should be noticed that, if as expected the studied forages could be interesting fiber sources for rabbit feeding (ADF = 21 to 39% DM, ADL= 6.5 to 24.6% DM)), their CP content is also high enough (15 to 29% DM) to provide a noticeable proportion of rabbits total protein requirement. Nevertheless their high level of potassium (1.4 to 3.9% DM) may limit their incorporation level in rabbit feeds. Determination of residual trypsin inhibitor activity indicated that traditional soybean seeds toasting was efficient since the residual activity was only 5.8 TUI/mg. Then with their high protein level (44.2% DM), local toasted soybean seeds should be considered as an interesting source of protein for rabbits